Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Kagami

Showing results (71-80 of 114) with videos related to

Pageof 12
Sort By:
Leukemia & Lymphoma|February 27, 1999
Histology according to the Revised European-American Lymphoma Classification significantly predicts the prognosis of ocular adnexal lymphomaM Nakata, Y Matsuno, N Katsumata, et al.
The American Journal of Surgical Pathology|June 1, 1997
A nodal gamma/delta T-cell lymphoma with an association of Epstein-Barr virusY Kagami, S Nakamura, R Suzuki, et al.
The American Journal of Surgical Pathology|March 1, 1995
Clinicopathologic study of CD56 (NCAM)-positive angiocentric lymphoma occurring in sites other than the upper and lower respiratory tractS Nakamura, T Suchi, T Koshikawa, et al.
Leukemia|November 1, 1991
Cytogenetic and clonal culture evaluation after response to low dose Ara-C in myelodysplastic syndromesT Hotta, S Goto, K Tsushita, et al.
Gan No Rinsho. Japan Journal of Cancer Clinics|April 1, 1986
[Results of brachytherapy of tongue cancer]M Nishio, T Sakurai, Y Kagami, et al.
Bone Marrow Transplantation|October 23, 1997
Complete cytogenetic response with host-derived hematopoiesis induced by cyclosporin A discontinuation in a patient with relapsed chronic myelogenous leukemia after bone marrow transplantationR Suzuki, H Taji, S Iida, et al.
Oncogene|February 12, 1998
Chimeric MLL products with a Ras binding cytoplasmic protein AF6 involved in t(6;11) (q27;q23) leukemia localize in the nucleusT Joh, K Yamamoto, Y Kagami, et al.
British Journal of Haematology|August 1, 1997
Complementarity determining region-III is a useful molecular marker for the evaluation of minimal residual disease in mantle cell lymphomaT Kurokawa, T Kinoshita, T Murate, et al.
International Journal of Radiation Oncology, Biology, Physics|December 21, 2000
Fractionated stereotactic radiotherapy of brain metastases from renal cell carcinomaH Ikushima, K Tokuuye, M Sumi, et al.
The Japanese Journal of Antibiotics|December 1, 1990
[Clinical evaluation of cefbuperazone in severe infections complicated with hematological disorders]H Mizuno, H Yamao, H Saito, et al.
Pageof 12

Showing results (71-80 of 114) with videos related to

Sort By:
Pageof 12
Leukemia & Lymphoma|February 27, 1999
Histology according to the Revised European-American Lymphoma Classification significantly predicts the prognosis of ocular adnexal lymphomaM Nakata, Y Matsuno, N Katsumata, et al.
The American Journal of Surgical Pathology|June 1, 1997
A nodal gamma/delta T-cell lymphoma with an association of Epstein-Barr virusY Kagami, S Nakamura, R Suzuki, et al.
The American Journal of Surgical Pathology|March 1, 1995
Clinicopathologic study of CD56 (NCAM)-positive angiocentric lymphoma occurring in sites other than the upper and lower respiratory tractS Nakamura, T Suchi, T Koshikawa, et al.
Leukemia|November 1, 1991
Cytogenetic and clonal culture evaluation after response to low dose Ara-C in myelodysplastic syndromesT Hotta, S Goto, K Tsushita, et al.
Gan No Rinsho. Japan Journal of Cancer Clinics|April 1, 1986
[Results of brachytherapy of tongue cancer]M Nishio, T Sakurai, Y Kagami, et al.
Bone Marrow Transplantation|October 23, 1997
Complete cytogenetic response with host-derived hematopoiesis induced by cyclosporin A discontinuation in a patient with relapsed chronic myelogenous leukemia after bone marrow transplantationR Suzuki, H Taji, S Iida, et al.
Oncogene|February 12, 1998
Chimeric MLL products with a Ras binding cytoplasmic protein AF6 involved in t(6;11) (q27;q23) leukemia localize in the nucleusT Joh, K Yamamoto, Y Kagami, et al.
British Journal of Haematology|August 1, 1997
Complementarity determining region-III is a useful molecular marker for the evaluation of minimal residual disease in mantle cell lymphomaT Kurokawa, T Kinoshita, T Murate, et al.
International Journal of Radiation Oncology, Biology, Physics|December 21, 2000
Fractionated stereotactic radiotherapy of brain metastases from renal cell carcinomaH Ikushima, K Tokuuye, M Sumi, et al.
The Japanese Journal of Antibiotics|December 1, 1990
[Clinical evaluation of cefbuperazone in severe infections complicated with hematological disorders]H Mizuno, H Yamao, H Saito, et al.
Pageof 12